Levy Adam Scott

CFO And Secretary | CFO, Chief Bus. Off. And Secy. | Chief Business Officer

2 companies

Weak

Trades Analyzed

12M Win Rate

0.0%

Avg 3M Return

-27.5%

Avg 12M Return

-57.4%

Levy Adam Scott is a Chief Business Officer at VRDN with holdings across 2 companies. Recent SEC Form 4 filings include 0 buys and 23 sells.

Estimated insider holdings value: $430K based on current market prices.

Holdings by Company

VRDNFeb 13, 2018

Current Shares10.5K

Value$175.1K

Net Activity+9.3K

Bought: 9.3KSold: 0

MLYSJan 12, 2026

Current Shares8.6K

Value$255.2K

Net Activity-359,069

Bought: 6.3KSold: 365.3K

Showing 10 filings

Date	Ticker	Role	Type	Shares	Price	Value	Chg%	3M	12M
Jan 12, 2026	MLYS Mineralys Therapeutics, Inc.	CFO And Secretary	Sell	10,758	$32.14	$345,723.39	-55.5%	-19.3%	-
Nov 11, 2025	MLYS Mineralys Therapeutics, Inc.	CFO And Secretary	Sale+OE	119,524	$44.88	$5,363,715.88	-12.1%	-32.6%	-
Oct 13, 2025	MLYS Mineralys Therapeutics, Inc.	CFO And Secretary	Sell	10,758	$42.01	$451,983.56	-4.3%	-23.4%	-
Jul 30, 2025	MLYS Mineralys Therapeutics, Inc.	CFO And Secretary	Sell	73,678	$14.62	$1,077,476.77	-10.0%	+180.7%	-
Jul 11, 2025	MLYS Mineralys Therapeutics, Inc.	CFO And Secretary	Sell	10,758	$14.45	$155,454.18	-4.9%	+171.8%	-
Apr 11, 2025	MLYS Mineralys Therapeutics, Inc.	CFO And Secretary	Sell	10,757	$12.06	$129,684.24	-4.8%	+9.3%	+98.7%
Jan 13, 2025	MLYS Mineralys Therapeutics, Inc.	CFO And Secretary	Sell	10,757	$9.10	$97,863.90	-2.3%	+48.7%	+251.9%
Oct 11, 2024	MLYS Mineralys Therapeutics, Inc.	CFO And Secretary	Sell	10,757	$13.57	$146,003.69	-4.3%	-27.2%	+210.9%
Jul 11, 2024	MLYS Mineralys Therapeutics, Inc.	CFO And Secretary	Sell	10,757	$13.14	$141,394.31	-4.2%	+1.0%	+6.8%
Jun 11, 2024	MLYS Mineralys Therapeutics, Inc.	CFO And Secretary	Sell	96,815	$12.94	$1,252,718.33	-27.5%	-8.9%	+19.7%